Recent insider trends for Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) have caught the attention of investors. Insider data is useful because it can reveal what a company’s executives and largest shareholders feel about a stock. In this case, the data has some interesting things to say about how EKSO might perform in the future.
Institutions own 03.45% of Ekso Bionics Holdings, Inc. (EKSO)’s shares. The total value of these holdings, in millions, is $4. Among active positions in the latest quarter, 22 holders increased their positions by a total of 805455 shares, 7 holders decreased the positions by a total of 28453 shares, and 12 holders held their positions. This works out to a net increase in ownership of 777002 shares, and suggests that institutions are feeling bullish about the stock.
Among new and sold out positions, 5 holders initiated new positions by a total of 93418 shares and 3 holders exited their positions by a total of 7908 shares. This nets out to an increase of 85510 shares and is a bullish sign for EKSO.
In the last three months, insiders executed a total of 6 trades. 5 of these were buys and 1 were sells. Insider ownership increased by a total of 64466 shares, which suggests that EKSO’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a different story: insiders executed 5 buys and 5 sells, and ownership decreased by a net of 185534 shares.
The analysis of insider buying and selling trends can be extended to the aggregate level. Short interest, which represents the number of a stock’s shares currently being shorted, captures what the market as a whole feels about a stock. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)’s short interest is 0 shares. This represents an increase in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.
Given what the insider ownership patterns are saying, it makes sense to consider the technicals to see if these pieces of information reach the same conclusion about the outlook for EKSO. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that EKSO is a buy, which implies that EKSO is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is undervalued.